Global Neurological Disorder Drugs Industry Market Research Report 1 Neurological Disorder Drugs Introduction and Market Overview 1.1 Objectives of the Study 1.2 Definition of Neurological Disorder Drugs 1.3 Neurological Disorder Drugs Market Scope and Market Size Estimation 1.3.1 Market Concentration Ratio and Market Maturity Analysis 1.3.2 Global Neurological Disorder Drugs Value ($) and Growth Rate from 2012-2022 1.4 Market Segmentation 1.4.1 Types of Neurological Disorder Drugs 1.4.2 Applications of Neurological Disorder Drugs 1.4.3 Research Regions 1.4.3.1 North America Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) 1.4.3.2 Europe Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) 1.4.3.3 China Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) 1.4.3.4 Japan Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) 1.4.3.5 Middle East & Africa Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) 1.4.3.6 India Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) 1.4.3.7 South America Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) 1.5 Market Dynamics 1.5.1 Drivers 1.5.1.1 Emerging Countries of Neurological Disorder Drugs 1.5.1.2 Growing Market of Neurological Disorder Drugs 1.5.2 Limitations 1.5.3 Opportunities 1.6 Industry News and Policies by Regions 1.6.1 Industry News 1.6.2 Industry Policies 2 Industry Chain Analysis 2.1 Upstream Raw Material Suppliers of Neurological Disorder Drugs Analysis 2.2 Major Players of Neurological Disorder Drugs 2.2.1 Major Players Manufacturing Base and Market Share of Neurological Disorder Drugs in 2016 2.2.2 Major Players Product Types in 2016 2.3 Neurological Disorder Drugs Manufacturing Cost Structure Analysis 2.3.1 Production Process Analysis 2.3.2 Manufacturing Cost Structure of Neurological Disorder Drugs 2.3.3 Raw Material Cost of Neurological Disorder Drugs 2.3.4 Labor Cost of Neurological Disorder Drugs 2.4 Market Channel Analysis of Neurological Disorder Drugs 2.5 Major Downstream Buyers of Neurological Disorder Drugs Analysis 3 Global Neurological Disorder Drugs Market, by Type 3.1 Analysis of Market Status and Feature by Type 3.2 Global Neurological Disorder Drugs Value ($) and Market Share by Type (2012-2017) 3.3 Global Neurological Disorder Drugs Production and Market Share by Type (2012-2017) 3.4 Global Neurological Disorder Drugs Value ($) and Growth Rate by Type (2012-2017) 3.5 Global Neurological Disorder Drugs Price Analysis by Type (2012-2017) 4 Neurological Disorder Drugs Market, by Application 4.1 Downstream Market Overview 4.2 Global Neurological Disorder Drugs Consumption and Market Share by Application (2012-2017) 4.3 Downstream Buyers by Application 4.4 Global Neurological Disorder Drugs Consumption and Growth Rate by Application (2012-2017) 5 Global Neurological Disorder Drugs Production, Value ($) by Region (2012-2017) 5.1 Global Neurological Disorder Drugs Value ($) and Market Share by Region (2012-2017) 5.2 Global Neurological Disorder Drugs Production and Market Share by Region (2012-2017) 5.3 Global Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) 5.4 North America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) 5.5 Europe Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) 5.6 China Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) 5.7 Japan Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) 5.8 Middle East & Africa Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) 5.9 India Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) 5.10 South America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) 6 Global Neurological Disorder Drugs Production, Consumption, Export, Import by Regions (2012-2017) 6.1 Global Neurological Disorder Drugs Consumption by Regions (2012-2017) 6.2 North America Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) 6.3 Europe Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) 6.4 China Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) 6.5 Japan Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) 6.6 Middle East & Africa Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) 6.7 India Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) 6.8 South America Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) 7 Global Neurological Disorder Drugs Market Status and SWOT Analysis by Regions 7.1 North America Neurological Disorder Drugs Market Status and SWOT Analysis 7.2 Europe Neurological Disorder Drugs Market Status and SWOT Analysis 7.3 China Neurological Disorder Drugs Market Status and SWOT Analysis 7.4 Japan Neurological Disorder Drugs Market Status and SWOT Analysis 7.5 Middle East & Africa Neurological Disorder Drugs Market Status and SWOT Analysis 7.6 India Neurological Disorder Drugs Market Status and SWOT Analysis 7.7 South America Neurological Disorder Drugs Market Status and SWOT Analysis 8 Competitive Landscape 8.1 Competitive Profile 8.2 GlaxoSmithKline plc 8.2.1 Company Profiles 8.2.2 Neurological Disorder Drugs Product Introduction and Market Positioning 8.2.2.1 Product Introduction 8.2.2.2 Market Positioning and Target Customers 8.2.3 GlaxoSmithKline plc Production, Value ($), Price, Gross Margin 2012-2017E 8.2.4 GlaxoSmithKline plc Market Share of Neurological Disorder Drugs Segmented by Region in 2016 8.3 Boehringer Ingelheim GmbH 8.3.1 Company Profiles 8.3.2 Neurological Disorder Drugs Product Introduction and Market Positioning 8.3.2.1 Product Introduction 8.3.2.2 Market Positioning and Target Customers 8.3.3 Boehringer Ingelheim GmbH Production, Value ($), Price, Gross Margin 2012-2017E 8.3.4 Boehringer Ingelheim GmbH Market Share of Neurological Disorder Drugs Segmented by Region in 2016 8.4 F. Hoffmann-La Roche Ltd. 8.4.1 Company Profiles 8.4.2 Neurological Disorder Drugs Product Introduction and Market Positioning 8.4.2.1 Product Introduction 8.4.2.2 Market Positioning and Target Customers 8.4.3 F. Hoffmann-La Roche Ltd. Production, Value ($), Price, Gross Margin 2012-2017E 8.4.4 F. Hoffmann-La Roche Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2016 8.5 Merck & Co. 8.5.1 Company Profiles 8.5.2 Neurological Disorder Drugs Product Introduction and Market Positioning 8.5.2.1 Product Introduction 8.5.2.2 Market Positioning and Target Customers 8.5.3 Merck & Co. Production, Value ($), Price, Gross Margin 2012-2017E 8.5.4 Merck & Co. Market Share of Neurological Disorder Drugs Segmented by Region in 2016 8.6 Bayer AG 8.6.1 Company Profiles 8.6.2 Neurological Disorder Drugs Product Introduction and Market Positioning 8.6.2.1 Product Introduction 8.6.2.2 Market Positioning and Target Customers 8.6.3 Bayer AG Production, Value ($), Price, Gross Margin 2012-2017E 8.6.4 Bayer AG Market Share of Neurological Disorder Drugs Segmented by Region in 2016 8.7 Novartis AG 8.7.1 Company Profiles 8.7.2 Neurological Disorder Drugs Product Introduction and Market Positioning 8.7.2.1 Product Introduction 8.7.2.2 Market Positioning and Target Customers 8.7.3 Novartis AG Production, Value ($), Price, Gross Margin 2012-2017E 8.7.4 Novartis AG Market Share of Neurological Disorder Drugs Segmented by Region in 2016 8.8 Teva Pharmaceutical Industries Ltd. 8.8.1 Company Profiles 8.8.2 Neurological Disorder Drugs Product Introduction and Market Positioning 8.8.2.1 Product Introduction 8.8.2.2 Market Positioning and Target Customers 8.8.3 Teva Pharmaceutical Industries Ltd. Production, Value ($), Price, Gross Margin 2012-2017E 8.8.4 Teva Pharmaceutical Industries Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2016 8.9 AstraZeneca 8.9.1 Company Profiles 8.9.2 Neurological Disorder Drugs Product Introduction and Market Positioning 8.9.2.1 Product Introduction 8.9.2.2 Market Positioning and Target Customers 8.9.3 AstraZeneca Production, Value ($), Price, Gross Margin 2012-2017E 8.9.4 AstraZeneca Market Share of Neurological Disorder Drugs Segmented by Region in 2016 9 Global Neurological Disorder Drugs Market Analysis and Forecast by Type and Application 9.1 Global Neurological Disorder Drugs Market Value ($) & Volume Forecast, by Type (2017-2022) 9.1.1 Antipsychotic Market Value ($) and Volume Forecast (2017-2022) 9.1.2 Hypnotic & Sedative Market Value ($) and Volume Forecast (2017-2022) 9.1.3 Analgesics Market Value ($) and Volume Forecast (2017-2022) 9.1.4 Anticoagulants Market Value ($) and Volume Forecast (2017-2022) 9.1.5 Others Market Value ($) and Volume Forecast (2017-2022) 9.2 Global Neurological Disorder Drugs Market Value ($) & Volume Forecast, by Application (2017-2022) 9.2.1 Hospital Market Value ($) and Volume Forecast (2017-2022) 9.2.2 Clinic Market Value ($) and Volume Forecast (2017-2022) 9.2.3 Home Market Value ($) and Volume Forecast (2017-2022) 10 Neurological Disorder Drugs Market Analysis and Forecast by Region 10.1 North America Market Value ($) and Consumption Forecast (2017-2022) 10.2 Europe Market Value ($) and Consumption Forecast (2017-2022) 10.3 China Market Value ($) and Consumption Forecast (2017-2022) 10.4 Japan Market Value ($) and Consumption Forecast (2017-2022) 10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2017-2022) 10.6 India Market Value ($) and Consumption Forecast (2017-2022) 10.7 South America Market Value ($) and Consumption Forecast (2017-2022) 11 New Project Feasibility Analysis 11.1 Industry Barriers and New Entrants SWOT Analysis 11.2 Analysis and Suggestions on New Project Investment 12 Research Finding and Conclusion 13 Appendix 13.1 Discussion Guide 13.2 Knowledge Store: Maia Subscription Portal 13.3 Research Data Source 13.4 Research Assumptions and Acronyms Used

List of Tables and Figures Figure Product Picture of Neurological Disorder Drugs Table Product Specification of Neurological Disorder Drugs Figure Market Concentration Ratio and Market Maturity Analysis of Neurological Disorder Drugs Figure Global Neurological Disorder Drugs Value ($) and Growth Rate from 2012-2022 Table Different Types of Neurological Disorder Drugs Figure Global Neurological Disorder Drugs Value ($) Segment by Type from 2012-2017 Figure Antipsychotic Picture Figure Hypnotic & Sedative Picture Figure Analgesics Picture Figure Anticoagulants Picture Figure Others Picture Table Different Applications of Neurological Disorder Drugs Figure Global Neurological Disorder Drugs Value ($) Segment by Applications from 2012-2017 Figure Hospital Picture Figure Clinic Picture Figure Home Picture Table Research Regions of Neurological Disorder Drugs Figure North America Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) Figure Europe Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) Table China Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) Table Japan Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) Table Middle East & Africa Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) Table India Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) Table South America Neurological Disorder Drugs Production Value ($) and Growth Rate (2012-2017) Table Emerging Countries of Neurological Disorder Drugs Table Growing Market of Neurological Disorder Drugs Figure Industry Chain Analysis of Neurological Disorder Drugs Table Upstream Raw Material Suppliers of Neurological Disorder Drugs with Contact Information Table Major Players Manufacturing Base and Market Share ($) of Neurological Disorder Drugs in 2016 Table Major Players Neurological Disorder Drugs Product Types in 2016 Figure Production Process of Neurological Disorder Drugs Figure Manufacturing Cost Structure of Neurological Disorder Drugs Figure Channel Status of Neurological Disorder Drugs Table Major Distributors of Neurological Disorder Drugs with Contact Information Table Major Downstream Buyers of Neurological Disorder Drugs with Contact Information Table Analysis of Market Status and Feature by Type Table Global Neurological Disorder Drugs Value ($) by Type (2012-2017) Table Global Neurological Disorder Drugs Value ($) Share by Type (2012-2017) Figure Global Neurological Disorder Drugs Value ($) Share by Type (2012-2017) Table Global Neurological Disorder Drugs Production by Type (2012-2017) Table Global Neurological Disorder Drugs Production Share by Type (2012-2017) Figure Global Neurological Disorder Drugs Production Share by Type (2012-2017) Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Antipsychotic Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Hypnotic & Sedative Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Analgesics Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Anticoagulants Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Others Table Global Neurological Disorder Drugs Price by Type (2012-2017) Figure Downstream Market Overview Table Global Neurological Disorder Drugs Consumption by Application (2012-2017) Table Global Neurological Disorder Drugs Consumption Market Share by Application (2012-2017) Figure Global Neurological Disorder Drugs Consumption Market Share by Application (2012-2017) Table Downstream Buyers Introduction by Application Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Hospital (2012-2017) Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Clinic (2012-2017) Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Home (2012-2017) Table Global Neurological Disorder Drugs Value ($) by Region (2012-2017) Table Global Neurological Disorder Drugs Value ($) Market Share by Region (2012-2017) Figure Global Neurological Disorder Drugs Value ($) Market Share by Region (2012-2017) Table Global Neurological Disorder Drugs Production by Region (2012-2017) Table Global Neurological Disorder Drugs Production Market Share by Region (2012-2017) Figure Global Neurological Disorder Drugs Production Market Share by Region (2012-2017) Table Global Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) Table North America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) Table Europe Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) Table China Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) Table Japan Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) Table Middle East & Africa Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) Table India Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) Table South America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2012-2017) Table Global Neurological Disorder Drugs Consumption by Regions (2012-2017) Figure Global Neurological Disorder Drugs Consumption Share by Regions (2012-2017) Table North America Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) Table Europe Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) Table China Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) Table Japan Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) Table Middle East & Africa Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) Table India Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) Table South America Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017) Figure North America Neurological Disorder Drugs Production and Growth Rate Analysis Figure North America Neurological Disorder Drugs Consumption and Growth Rate Analysis Figure North America Neurological Disorder Drugs SWOT Analysis Figure Europe Neurological Disorder Drugs Production and Growth Rate Analysis Figure Europe Neurological Disorder Drugs Consumption and Growth Rate Analysis Figure Europe Neurological Disorder Drugs SWOT Analysis Figure China Neurological Disorder Drugs Production and Growth Rate Analysis Figure China Neurological Disorder Drugs Consumption and Growth Rate Analysis Figure China Neurological Disorder Drugs SWOT Analysis Figure Japan Neurological Disorder Drugs Production and Growth Rate Analysis Figure Japan Neurological Disorder Drugs Consumption and Growth Rate Analysis Figure Japan Neurological Disorder Drugs SWOT Analysis Figure Middle East & Africa Neurological Disorder Drugs Production and Growth Rate Analysis Figure Middle East & Africa Neurological Disorder Drugs Consumption and Growth Rate Analysis Figure Middle East & Africa Neurological Disorder Drugs SWOT Analysis Figure India Neurological Disorder Drugs Production and Growth Rate Analysis Figure India Neurological Disorder Drugs Consumption and Growth Rate Analysis Figure India Neurological Disorder Drugs SWOT Analysis Figure South America Neurological Disorder Drugs Production and Growth Rate Analysis Figure South America Neurological Disorder Drugs Consumption and Growth Rate Analysis Figure South America Neurological Disorder Drugs SWOT Analysis Figure Competitive Matrix and Pattern Characteristics of Neurological Disorder Drugs Market Figure Top 3 Market Share of Neurological Disorder Drugs Companies Figure Top 6 Market Share of Neurological Disorder Drugs Companies Table Mergers, Acquisitions and Expansion Analysis Table Company Profiles Table Product Introduction Table Market Positioning and Target Customers Table GlaxoSmithKline plc Production, Value ($), Price, Gross Margin 2012-2017E Figure GlaxoSmithKline plc Production and Growth Rate Figure GlaxoSmithKline plc Value ($) Market Share 2012-2017E Figure GlaxoSmithKline plc Market Share of Neurological Disorder Drugs Segmented by Region in 2016 Table Company Profiles Table Product Introduction Table Market Positioning and Target Customers Table Boehringer Ingelheim GmbH Production, Value ($), Price, Gross Margin 2012-2017E Figure Boehringer Ingelheim GmbH Production and Growth Rate Figure Boehringer Ingelheim GmbH Value ($) Market Share 2012-2017E Figure Boehringer Ingelheim GmbH Market Share of Neurological Disorder Drugs Segmented by Region in 2016 Table Company Profiles Table Product Introduction Table Market Positioning and Target Customers Table F. Hoffmann-La Roche Ltd. Production, Value ($), Price, Gross Margin 2012-2017E Figure F. Hoffmann-La Roche Ltd. Production and Growth Rate Figure F. Hoffmann-La Roche Ltd. Value ($) Market Share 2012-2017E Figure F. Hoffmann-La Roche Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2016 Table Company Profiles Table Product Introduction Table Market Positioning and Target Customers Table Merck & Co. Production, Value ($), Price, Gross Margin 2012-2017E Figure Merck & Co. Production and Growth Rate Figure Merck & Co. Value ($) Market Share 2012-2017E Figure Merck & Co. Market Share of Neurological Disorder Drugs Segmented by Region in 2016 Table Company Profiles Table Product Introduction Table Market Positioning and Target Customers Table Bayer AG Production, Value ($), Price, Gross Margin 2012-2017E Figure Bayer AG Production and Growth Rate Figure Bayer AG Value ($) Market Share 2012-2017E Figure Bayer AG Market Share of Neurological Disorder Drugs Segmented by Region in 2016 Table Company Profiles Table Product Introduction Table Market Positioning and Target Customers Table Novartis AG Production, Value ($), Price, Gross Margin 2012-2017E Figure Novartis AG Production and Growth Rate Figure Novartis AG Value ($) Market Share 2012-2017E Figure Novartis AG Market Share of Neurological Disorder Drugs Segmented by Region in 2016 Table Company Profiles Table Product Introduction Table Market Positioning and Target Customers Table Teva Pharmaceutical Industries Ltd. Production, Value ($), Price, Gross Margin 2012-2017E Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2012-2017E Figure Teva Pharmaceutical Industries Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2016 Table Company Profiles Table Product Introduction Table Market Positioning and Target Customers Table AstraZeneca Production, Value ($), Price, Gross Margin 2012-2017E Figure AstraZeneca Production and Growth Rate Figure AstraZeneca Value ($) Market Share 2012-2017E Figure AstraZeneca Market Share of Neurological Disorder Drugs Segmented by Region in 2016 Table Global Neurological Disorder Drugs Market Value ($) Forecast, by Type Table Global Neurological Disorder Drugs Market Volume Forecast, by Type Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Antipsychotic (2017-2022) Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Antipsychotic (2017-2022) Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Hypnotic & Sedative (2017-2022) Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Hypnotic & Sedative (2017-2022) Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Analgesics (2017-2022) Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Analgesics (2017-2022) Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Anticoagulants (2017-2022) Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Anticoagulants (2017-2022) Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Others (2017-2022) Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Others (2017-2022) Table Global Market Value ($) Forecast by Application (2017-2022) Table Global Market Volume Forecast by Application (2017-2022) Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Hospital (2012-2017) Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Clinic (2012-2017) Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Home (2012-2017) Figure Market Value ($) and Growth Rate Forecast of Home (2017-2022) Figure Market Volume and Growth Rate Forecast of Home (2017-2022) Figure North America Market Value ($) and Growth Rate Forecast (2017-2022) Table North America Consumption and Growth Rate Forecast (2017-2022) Figure Europe Market Value ($) and Growth Rate Forecast (2017-2022) Table Europe Consumption and Growth Rate Forecast (2017-2022) Figure China Market Value ($) and Growth Rate Forecast (2017-2022) Table China Consumption and Growth Rate Forecast (2017-2022) Figure Japan Market Value ($) and Growth Rate Forecast (2017-2022) Table Japan Consumption and Growth Rate Forecast (2017-2022) Figure Middle East & Africa Market Value ($) and Growth Rate Forecast (2017-2022) Table Middle East & Africa Consumption and Growth Rate Forecast (2017-2022) Figure India Market Value ($) and Growth Rate Forecast (2017-2022) Table India Consumption and Growth Rate Forecast (2017-2022) Figure South America Market Value ($) and Growth Rate Forecast (2017-2022) Table South America Consumption and Growth Rate Forecast (2017-2022) Figure Industry Resource/Technology/Labor Importance Analysis Table New Entrants SWOT Analysis Table New Project Analysis of Investment Recovery